PCI looks to Boston for growth; 3M signs on to help Mylan make generic Advair;

> Contract drugmaker PCI Synthesis is increasingly looking to its native Boston for partnership deals, tapping the area's fast-growing biotech ecosystem to flesh out its client base. Story

> 3M ($MMM) has signed on to help Mylan ($MYL) manufacture the delivery device key to its generic version of GlaxoSmithKline's ($GSK) blockbuster COPD treatment Advair. News

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.